Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Vaxcyte said the concurrent equity and debt offerings closed on Oct. 9. The company said it sold 7,412,500 shares, pre-funded warrants for 400,000 shares and $500 million of 1.50% convertible senior notes due 2032, with over-allotment options exercised in full.
Vaxcyte (PCVX) announced the closing of its $1.15 billion public offerings of common stock, pre-funded warrants, and convertible senior notes, including full exercise of underwriters’ options to purchase additional shares and convertible senior notes.